Management of atrial fibrillation and flutter

References

• Gheorghiade M, Beller GA. Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol 1983: 51(8): 1243–50
   PubMed Web of Science ®Google Scholar
• Smith TW, Haber E. Digitalis. N Engl J Med 1973: 289(18): 945–52
   PubMed Web of Science ®Google Scholar
• Gillis RA. Digitalis: a neuroexcitatory drug. Circulation 1975: 52(5): 739–42
   PubMed Web of Science ®Google Scholar
• Mendez C, Aceves J, Mendez R. The anti-adrenergic action of digitalis on the refractory period of the A-V transmission system. J Pharmacol Exp Ther 1961: 131 (Feb): 199–204
   PubMedGoogle Scholar
• Lown B, Graboys TB, Podrid PJ, et al. Effect of a digitalis drug on ventricular premature beats. N Engl J Med 1977: 296(6): 301–6
   PubMed Web of Science ®Google Scholar
• Goodman DJ, Rossen RM, Cannom DS, et al. Effect of digoxin on atrioventricular conduction: studies in patients with and without cardiac autonomic innervation. Circulation 1975: 51(2): 251–6
   PubMed Web of Science ®Google Scholar
• Prystowsky EN, Naccarelli GV, Jackman WM, et al. Enhanced parasympathetic tone shortens atrial refractoriness In man. Am J Cardiol 1983: 51(1): 96–100
   PubMed Web of Science ®Google Scholar
• Engel TR, Gonzalez AD. Effects of digitalis on atrial vulnerability. Am J Cardiol 1978: 42(4): 570–6
   PubMed Web of Science ®Google Scholar
• Moe GK, Farah AE. Digitalis and allied cardiac glycosides. In: Goodman LS. Gilman A. eds. Pharmacological basis of therapeutics. 4th ed. New York: Macmillan, 1970: 677–708
   Google Scholar
• Weiner P, Bassan MM, Jarchorsky J, et al. Clinical course of acute atrial fibrillation treated with rapid digitallzation. Am Heart J 1983: 105(2): 223–7
   PubMed Web of Science ®Google Scholar
• Gold RL, Bren GB, Katz RJ, et al. Independent and Interactive effects of digoxin and quinidine on the atrial fibrillation threshold In dogs. J Am Coll Cardiol 1985: 6(1): 119–23
   PubMed Web of Science ®Google Scholar
• Coumel P, Leclercq JF. Role of the autonomic nervous system in the genesis of clinical arrhythmias. In: Rosenbaum MB, Elizari MV. eds. Frontiers of cardiac electrophysiology. Hingham. MA: Kluwer Academic (Martinus Nijhoff). 1983: 552–81
   Google Scholar
• Goldman S, Probst P, Selzer A, et al. Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate In atrial fibrillation. Am J Cardiol 1975: 35(5): 651–5
   PubMed Web of Science ®Google Scholar
• David D, Segni ED, Klein HO, et al. Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent. Am J Cardiol 1979: 44(7): 1378–82
   PubMed Web of Science ®Google Scholar
• Klein HO, Kaplinsky E. Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction. Am J Cardiol 1982: 50(4): 894–902
   PubMed Web of Science ®Google Scholar
• Doherty JE, de Soyza N, Kane JJ, et al. Clinical pharmacokinetics of digitalis glycosides. Prog Cardiovasc Dis 1978: 21(2): 141–58
   PubMed Web of Science ®Google Scholar
• Iisalo E. Clinical pharmacokinetics of digoxin. Clin Pharmacokinet 1977: 2(1): 1–16
   PubMed Web of Science ®Google Scholar
• Smith TW, Braunwald E. The management of heart failure. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. Vol 1. Philadelphia: WB Saunders. 1980: 538–70
   Google Scholar
• Lindenbaum J, Mellow MH, Blackstone MO, et al. Variation in biologic availability of digoxin from four preparations. N Engl J Med 1971: 285(24): 1344–7
   PubMed Web of Science ®Google Scholar
• Binnion PF. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin. J Clin Pharmacol 1976: 16(10 Pt 1): 461–7
   PubMed Web of Science ®Google Scholar
• Koch-Weser J. Bioavailability of drugs. N Engl J Med 1974: 291(Sep 5): 503–6
   PubMed Web of Science ®Google Scholar
• Kim YI, Noble RJ, Zipes DP. Dissociation of the inotropic effect of digitalis from its effect on atrioventricular conduction. Am J Cardiol 1975: 36(4): 459–67
   PubMed Web of Science ®Google Scholar
• Chamberlain DA, White RJ, Howard MR, et al. Plasma digoxin concentrations In patients with atrial fibrillation. Br Med J 1970: 3(Aug): 429–32
   PubMedGoogle Scholar
• Doherty JE. How and when to use the digitalis serum levels. JAMA 1978: 239(24): 2594–6
   PubMed Web of Science ®Google Scholar
• Shapiro W. Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication. Am J Cardiol 1976: 41(May 1): 852–9
   Web of Science ®Google Scholar
• Duhme DW, Greenblatt DJ, Koch-Weser J. Reduction of digoxin toxicity associated with measurement of serum levels: a report from the Boston Collaborative Drug Surveillance Program. Ann Intern Med 1974: 80(Apr): 516–9
   PubMedGoogle Scholar
• Beller GA. Smith TW, Abelmann WH, et al. Digitalis intoxication: a prospective clinical study with serum level correlations. N Engl J Med 1971: 284(18): 989–97
   PubMed Web of Science ®Google Scholar
• Iesaka Y, Aonuma K, Gosselin AJ, et al. Susceptibility of infarcted canine hearts to digitalis-toxic ventricular tachycardia. J Am Coll Cardiol 1983: 2(1): 45–51
   PubMed Web of Science ®Google Scholar
• Ewy GA, Kapadia GG, Yao L, et al. Digoxin metabolism in the elderly. Circulation 1969: 39(Apr): 449–53
   PubMedGoogle Scholar
• Storstein O, Rasmussen K. Digitalis and atrial tachycardia with block. Br Heart J 1974: 36(2): 171–6
   PubMedGoogle Scholar
• Resnekov L. Cardiac arrhythmias. 6. Present status of electroversion in the management of cardiac dysrhythmias. Circulation 1973: 47(Jun): 1356–63
   PubMedGoogle Scholar
• Smith TW, Butler VP Jr, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific fab antibody fragments: experience In 26 cases. N Engl J Med 1982: 307(22): 1357–62
   PubMed Web of Science ®Google Scholar
• Rahimtoola SH, Gunnar RM. Digitalis in acute myocardial infarction: help or hazard? Ann Intern Med 1975: 82(2): 234–40
   PubMed Web of Science ®Google Scholar
• Lown B, Klein MD, Barr I, et al. Sensitivity to digitalis drugs in acute myocardial infarction. Am J Cardiol 1972: 30(4): 388–95
   PubMed Web of Science ®Google Scholar
• Sellers TD Jr, Bashore TM, Gallagher JJ. Digitalis in the pre-excitation syndrome: analysis during atrial fibrillation. Circulation 1977: 56(2): 260–7
   PubMed Web of Science ®Google Scholar
• Margolis JR. Strauss HC, Miller HC, et al. Digitalis and the sick sinus syndrome: clinical and electro-physiologic documentation of a severe toxic effect on sinus node function. Circulation 1975: 52(1): 162–9
   PubMed Web of Science ®Google Scholar
• Mason DT, Awan NA. Recent advances in digitalis research. Am J Cardiol 1979: 43(5): 1056–9
   PubMed Web of Science ®Google Scholar
• Lely AH, Enter CH van. Large-scale digitoxin intoxication. Br Med J 1970: 3(Sep): 737–40
   PubMedGoogle Scholar
• Leahey EB Jr, Reiffel JA, Drusin RE, et al. Interaction between quinidine and digoxin. JAMA 1978: 240(6): 533–44
   PubMed Web of Science ®Google Scholar
• Klein HO, Lang R, Di Segni E, et al. Verapamil-digoxin interaction. (Letter) N Engl J Med 1980: 303(3): 160
   PubMed Web of Science ®Google Scholar
• Leahey EB Jr, Reiffel JA, Giardina EG, et al. The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin: a prospective study. Ann Intern Med 1980: 92(5): 605–8
   PubMed Web of Science ®Google Scholar